{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:30:21Z","timestamp":1787671821696,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02499-9","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:19:22Z","timestamp":1787620762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HOXC9 transcriptionally activates NRP1 to promote cell malignant progression and immune evasion in colorectal cancer"],"prefix":"10.1007","volume":"301","author":[{"given":"Xiaofeng","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"7","key":"2499_CR1","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.21037\/tcr-21-373","volume":"10","author":"YM Cao","year":"2021","unstructured":"Cao YM, Wen D, Qu N, Zhu YX (2021) Prognostic and clinical significance of HOXC9 and HOXD10 in papillary thyroid cancer. Translational cancer Res 10(7):3317\u20133325","journal-title":"Translational cancer Res"},{"issue":"3","key":"2499_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3892\/ol.2023.13688","volume":"25","author":"H Che","year":"2023","unstructured":"Che H, Zheng Q, Liao Z, Zhang L (2023) HNF4G accelerates glioma progression by facilitating NRP1 transcription. Oncol Lett 25(3):102","journal-title":"Oncol Lett"},{"issue":"5","key":"2499_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188775","volume":"1877","author":"Y Chen","year":"2022","unstructured":"Chen Y, Bai B, Ying K, Pan H, Xie B (2022) Anti-PD-1 combined with targeted therapy: theory and practice in gastric and colorectal cancer. Biochim Biophys Acta Rev Cancer 1877(5):188775","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2499_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101851","volume":"40","author":"X Chen","year":"2024","unstructured":"Chen X, Chen LJ, Peng XF, Deng L, Wang Y, Li JJ et al (2024) Anti-PD-1\/PD-L1 therapy for colorectal cancer: clinical implications and future considerations. Transl Oncol 40:101851","journal-title":"Transl Oncol"},{"issue":"4","key":"2499_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.7150\/jca.103482","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Han J, Li S, Yang X, Yang S, Xu C et al (2025) HOXC-AS1 and EZH2 interaction increase HOXC9 expression and promote the malignant transformation of oral leukoplakia. J Cancer 16(4):1202\u20131214","journal-title":"J Cancer"},{"issue":"2","key":"2499_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000967","volume":"8","author":"CA Chuckran","year":"2020","unstructured":"Chuckran CA, Liu C, Bruno TC, Workman CJ, Vignali DA (2020) Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy. J Immunother Cancer 8(2):e000967","journal-title":"J Immunother Cancer"},{"issue":"10","key":"2499_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/BCJ20240607","volume":"482","author":"H Deng","year":"2025","unstructured":"Deng H, Xu Q, Zhang Q, Liu C, Ren L (2025) EZH2 promotes chemoresistance in colorectal cancer by inhibiting autophagy through NRP1 suppression. Biochem J 482(10):569\u2013581","journal-title":"Biochem J"},{"key":"2499_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.semcancer.2021.02.012","volume":"82","author":"L Du","year":"2022","unstructured":"Du L, Cheng Q, Zheng H, Liu J, Liu L, Chen Q (2022) Targeting stemness of cancer stem cells to fight colorectal cancers. Sem Cancer Biol 82:150\u2013161","journal-title":"Sem Cancer Biol"},{"issue":"9","key":"2499_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S et al (2024) Colorectal cancer: recent advances in management and treatment. World J Clin Oncol 15(9):1136\u201356","journal-title":"World J Clin Oncol"},{"issue":"14","key":"2499_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143455","volume":"14","author":"P Fernandez-Palanca","year":"2022","unstructured":"Fernandez-Palanca P, Payo-Serafin T, Fondevila F, Mendez-Blanco C, San-Miguel B, Romero MR et al (2022) Neuropilin-1 as a potential biomarker of prognosis and invasive-related parameters in liver and colorectal cancer: a systematic review and meta-analysis of human studies. Cancers (Basel) 14(14):3455","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2499_CR11","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.immuni.2023.09.004","volume":"56","author":"E Ghorani","year":"2023","unstructured":"Ghorani E, Swanton C, Quezada SA (2023) Cancer cell-intrinsic mechanisms driving acquired immune tolerance. Immunity 56(10):2270\u20132295","journal-title":"Immunity"},{"issue":"10","key":"2499_CR12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles JR, Globig AM, Kaech SM, Wherry EJ (2023) CD8(+) T cells in the cancer-immunity cycle. Immunity 56(10):2231\u20132253","journal-title":"Immunity"},{"issue":"11","key":"2499_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","volume":"11","author":"Q Gou","year":"2020","unstructured":"Gou Q, Dong C, Xu H, Khan B, Jin J, Liu Q et al (2020) PD-L1 degradation pathway and immunotherapy for cancer. Cell Death Dis 11(11):955","journal-title":"Cell Death Dis"},{"key":"2499_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102001","volume":"46","author":"Z Gui","year":"2024","unstructured":"Gui Z, Ye Y, Li Y, Ren Z, Wei N, Liu L et al (2024) Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in cervical cancer. Transl Oncol 46:102001","journal-title":"Transl Oncol"},{"issue":"1","key":"2499_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12957-023-02969-z","volume":"21","author":"J He","year":"2023","unstructured":"He J, Jiang M, Liu J, Zhu R, Lv W, Lian R et al (2023) Homeobox D9 drives the malignant phenotypes and enhances the programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter. World J Surg Oncol 21(1):93","journal-title":"World J Surg Oncol"},{"key":"2499_CR16","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2019.190122","author":"M Hu","year":"2019","unstructured":"Hu M, Ou-Yang W, Jing D, Chen R (2019) Clinical prognostic significance of HOXC9 expression in patients with colorectal cancer. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190122","journal-title":"Clin Lab"},{"issue":"15","key":"2499_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423490122","volume":"122","author":"C Huang","year":"2025","unstructured":"Huang C, Wang L, Zhuo C (2025) ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion. Proc Natl Acad Sci U S A 122(15):e2423490122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2499_CR18","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y (2019) PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vacc Immunother 15(5):1111\u20131122","journal-title":"Hum Vacc Immunother"},{"issue":"1","key":"2499_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1248\/bpb.b23-00630","volume":"47","author":"L Jin","year":"2024","unstructured":"Jin L, Jin A, Wang L, Qi X, Jin Y, Zhang C et al (2024) NRP1 induces enhanced stemness and chemoresistance in glioma cells via YAP. Biol Pharm Bull 47(1):166\u2013174","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"2499_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L (2023) Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg 15(4):495\u2013519","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"2499_CR21","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41467-019-11280-z","volume":"10","author":"M Leclerc","year":"2019","unstructured":"Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P et al (2019) Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun 10(1):3345","journal-title":"Nat Commun"},{"key":"2499_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.602068","volume":"7","author":"H Li","year":"2020","unstructured":"Li H, Wang X, Zhang M, Wang M, Zhang J, Ma S (2020) Identification of HOXA1 as a novel biomarker in prognosis of head and neck squamous cell carcinoma. Front Mol Biosci 7:602068","journal-title":"Front Mol Biosci"},{"key":"2499_CR23","doi-asserted-by":"publisher","first-page":"e18761429259562","DOI":"10.2174\/0118761429259562230925055749","volume":"17","author":"L Liang","year":"2024","unstructured":"Liang L, Li Y, Jiao Y, Zhang C, Shao M, Jiang H et al (2024) Maprotiline prompts an antitumour effect by inhibiting PD-L1 expression in mice with melanoma. Curr Mol Pharmacol 17:e18761429259562","journal-title":"Curr Mol Pharmacol"},{"issue":"Suppl 9","key":"2499_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12920-020-00775-0","volume":"13","author":"J Liu","year":"2020","unstructured":"Liu J, Dong C, Jiang G, Lu X, Liu Y, Wu H (2020) Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice. BMC Med Genom 13(Suppl 9):135","journal-title":"BMC Med Genom"},{"issue":"5","key":"2499_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S (2024) Hallmarks of cancer stemness. Cell Stem Cell 31(5):617\u2013639","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2499_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.4251\/wjgo.v16.i4.1119","volume":"16","author":"SR Lopes","year":"2024","unstructured":"Lopes SR, Martins C, Santos IC, Teixeira M, Gamito E, Alves AL (2024) Colorectal cancer screening: a review of current knowledge and progress in research. World J Gastrointest Oncol 16(4):1119\u20131133","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"2499_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000543921","volume":"106","author":"T Matsuda","year":"2025","unstructured":"Matsuda T, Fujimoto A, Igarashi Y (2025) Colorectal cancer: epidemiology, risk factors, and public health strategies. Digestion 106(2):91\u201399","journal-title":"Digestion"},{"issue":"5","key":"2499_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100049","volume":"22","author":"F Mou","year":"2025","unstructured":"Mou F, Sun Q, Ye Z (2025) Advances in the combination of immunotherapy and radiotherapy for microsatellite-stable metastatic colorectal cancer. Curr Proteomics 22(5):100049","journal-title":"Curr Proteomics"},{"issue":"10","key":"2499_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114819","volume":"43","author":"DB Poschel","year":"2024","unstructured":"Poschel DB, Klement JD, Merting AD, Lu C, Zhao Y, Yang D et al (2024) PD-L1 restrains PD-1(+)Nrp1(lo) Treg cells to suppress inflammation-driven colorectal tumorigenesis. Cell Rep 43(10):114819","journal-title":"Cell Rep"},{"issue":"5","key":"2499_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden M, Spranger S (2025) Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat Rev Immunol 25(5):353\u2013369","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2499_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3748\/wjg.v29.i8.1289","volume":"29","author":"MR Saraiva","year":"2023","unstructured":"Saraiva MR, Rosa I, Claro I (2023) Early-onset colorectal cancer: A review of current knowledge. World J Gastroenterol 29(8):1289\u20131303","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2499_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-023-10159-2","volume":"43","author":"US Shenoy","year":"2024","unstructured":"Shenoy US, Adiga D, Alhedyan F, Kabekkodu SP, Radhakrishnan R (2024) HOXA9 transcription factor is a double-edged sword: from development to cancer progression. Cancer Metastasis Rev 43(2):709\u2013728","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"2499_CR33","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1136\/gutjnl-2025-335412","volume":"74","author":"C Steup","year":"2025","unstructured":"Steup C, Kennel KB, Neurath MF, Fichtner-Feigl S, Greten FR (2025) Current and emerging concepts for systemic treatment of metastatic colorectal cancer. Gut 74(12):2070\u20132095","journal-title":"Gut"},{"issue":"11","key":"2499_CR34","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1161\/CIRCRESAHA.111.244095","volume":"108","author":"SJ Stoll","year":"2011","unstructured":"Stoll SJ, Bartsch S, Augustin HG, Kroll J (2011) The transcription factor HOXC9 regulates endothelial cell quiescence and vascular morphogenesis in zebrafish via inhibition of interleukin 8. Circul Res 108(11):1367\u20131377","journal-title":"Circul Res"},{"issue":"1","key":"2499_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","volume":"39","author":"Q Tang","year":"2020","unstructured":"Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z et al (2020) TM4SF1 promotes EMT and cancer stemness via the Wnt\/beta-catenin\/SOX2 pathway in colorectal cancer. J experimental Clin cancer research: CR 39(1):232","journal-title":"J experimental Clin cancer research: CR"},{"issue":"9","key":"2499_CR35","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1111\/cas.15043","volume":"112","author":"Y Tang","year":"2021","unstructured":"Tang Y, Wang T, Yu Y, Yan Y, Wu C (2021) Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1\/RIG1\/STAT1 axis. Cancer Sci 112(9):3455\u20133468","journal-title":"Cancer Sci"},{"issue":"1","key":"2499_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N (2025) Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target therapy 10(1):227","journal-title":"Signal Transduct Target therapy"},{"issue":"11","key":"2499_CR38","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.4049\/jimmunol.2300388","volume":"212","author":"C Vemulawada","year":"2024","unstructured":"Vemulawada C, Renavikar PS, Crawford MP, Steward-Tharp S, Karandikar NJ (2024) Disruption of IFNgamma, GZMB, PRF1, or LYST Results in Reduced Suppressive Function in Human CD8\u2009+\u2009T Cells. J Immunol 212(11):1722\u20131732","journal-title":"J Immunol"},{"issue":"1\u20132","key":"2499_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-022-01784-3","volume":"28","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang L, Sun XL, Lu YC, Chen S, Pei DS et al (2023) NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer. Apoptosis: Int J Program cell death 28(1\u20132):233\u2013246","journal-title":"Apoptosis: Int J Program cell death"},{"issue":"8","key":"2499_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41419-024-07017-6","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang M, Yi J, Gao H, Wei X, Xu W, Zhao M et al (2024) Radiation-induced YAP\/TEAD4 binding confers non-small cell lung cancer radioresistance via promoting NRP1 transcription. Cell Death Dis 15(8):619","journal-title":"Cell Death Dis"},{"issue":"9","key":"2499_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112919","volume":"28","author":"M Xu","year":"2025","unstructured":"Xu M, Sun Z, Wang D, Li G, Feng W, Qiao C et al (2025) Integrative multi-omics analysis decodes HOXC9-driven malignant transformation and metastasis in OSCC. iScience 28(9):112919","journal-title":"iScience"},{"issue":"6","key":"2499_CR42","first-page":"819","volume":"18","author":"F Xuan","year":"2016","unstructured":"Xuan F, Huang M, Liu W, Ding H, Yang L, Cui H (2016) Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. Neurooncology 18(6):819\u2013829","journal-title":"Neurooncology"},{"issue":"8","key":"2499_CR43","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1007\/s12010-023-04443-8","volume":"195","author":"C Yi","year":"2023","unstructured":"Yi C, Wei W, Wan M, Chen Y, Zhang B, Wu W (2023) Expression patterns of HOX gene family defines tumor microenvironment and immunotherapy in hepatocellular carcinoma. Appl Biochem Biotechnol 195(8):5072\u20135093","journal-title":"Appl Biochem Biotechnol"},{"issue":"9","key":"2499_CR44","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.5306\/wjco.v15.i9.1168","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li J (2024) Recent advancements in understanding of biological role of homeobox C9 in human cancers. World J Clin Oncol 15(9):1168\u20131176","journal-title":"World J Clin Oncol"},{"key":"2499_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2147\/OTT.S509625","volume":"18","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Sun H, Bo W, An Z, Li J (2025) Integrating bulk and single-cell RNA sequencing data reveals the prognostic significance of HOXC9-related immune gene signatures in hepatocellular carcinoma. OncoTargets Ther 18:453\u2013465","journal-title":"OncoTargets Ther"},{"issue":"12","key":"2499_CR46","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1007\/s10147-020-01772-0","volume":"25","author":"XF Zhao","year":"2020","unstructured":"Zhao XF, Yang YS, Park YK (2020) HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients. Int J Clin Oncol 25(12):2044\u20132054","journal-title":"Int J Clin Oncol"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02499-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:53:45Z","timestamp":1787669625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02499-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02499-9","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures performed on all animals complied with the standards formulated by the Experimental Animal Ethics Committee of Seventh People\u2019s Hospital of Shanghai University of Traditional Chinese Medicine and obtained the approval of the said committee.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"173"}}